[HTML][HTML] Monoclonal antibody anti-PBP2a protects mice against MRSA (methicillin-resistant Staphylococcus aureus) infections
FB Saraiva, ACC de Araújo, AÉV de Araújo… - PLoS …, 2019 - journals.plos.org
Methicillin-resistant Staphylococcus aureus (MRSA) is a multidrug-resistant bacterium
responsible for serious nosocomial and community-acquired infections worldwide. Since …
responsible for serious nosocomial and community-acquired infections worldwide. Since …
Passive immunization against methicillin resistant Staphylococcus aureus recombinant PBP2a in sepsis model of mice: comparable results with antibiotic therapy
RZ Naghshbandi, S Haghighat, M Mahdavi - International …, 2018 - Elsevier
Methicillin resistant Staphylococcus aureus (MRSA) is a representative pathogen that is
responsible for a nosocomial infection and considerable yearly mortality rate. Antibiotic …
responsible for a nosocomial infection and considerable yearly mortality rate. Antibiotic …
Recombinant PBP2a of methicillin-resistant S. aureus formulation in Alum and Montanide ISA266 adjuvants induced cellular and humoral immune responses with …
SS Mortazavi, S Haghighat, M Mahdavi - Microbial pathogenesis, 2020 - Elsevier
Staphylococcus aureus is an important cause of both hospital and community acquired
infections worldwide. S. aureus can develop multidrug resistance; thus, immunotherapy can …
infections worldwide. S. aureus can develop multidrug resistance; thus, immunotherapy can …
Treatment and prevention of enterococcal infections–alternative and experimental approaches
S Koch, M Hufnagel, J Huebner - Expert opinion on biological …, 2004 - Taylor & Francis
Enterococci are one of the leading types of organisms isolated from infections of
hospitalised patients and the third most common cause of nosocomial bloodstream …
hospitalised patients and the third most common cause of nosocomial bloodstream …
[PDF][PDF] 176 例新生儿败血症临床分析
朱绪亮, 杨嘉琛, 吴星恒, 赵玲, 陈晓 - 中国当代儿科杂志, 2009 - zgddek.com
&& 新生儿败血症是新生儿期较严重的感染性疾病, 在我国其发病率及病死率仍较高.
本文通过回顾分析南昌大学第一附属医院# $$# 年G 月至# $$" 年Y 月! GY …
本文通过回顾分析南昌大学第一附属医院# $$# 年G 月至# $$" 年Y 月! GY …
Recombinant PBP2a as a vaccine candidate against methicillin-resistant Staphylococcus aureus: Immunogenicity and protectivity
S Haghighat, SD Siadat, SMR Sorkhabadi… - Microbial …, 2017 - Elsevier
Methicillin-resistant Staphylococcus aureus infections are focal and development of an
effective vaccine can help to control this infection. Here, recombinant PBP2a was studied in …
effective vaccine can help to control this infection. Here, recombinant PBP2a was studied in …
[HTML][HTML] Prediction of Burkholderia pseudomallei DsbA substrates identifies potential virulence factors and vaccine targets
Identification of bacterial virulence factors is critical for understanding disease pathogenesis,
drug discovery and vaccine development. In this study we used two approaches to predict …
drug discovery and vaccine development. In this study we used two approaches to predict …
Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding …
R Therrien, P Lacasse, G Grondin, BG Talbot - Vaccine, 2007 - Elsevier
Collagen-binding protein (CNA) is the major Staphylococcus aureus adhesin responsible for
high affinity binding to collagen and is assumed to be a major virulence factor in infection …
high affinity binding to collagen and is assumed to be a major virulence factor in infection …